570 results on '"Limdi, Nita A."'
Search Results
2. Advancing genomics to improve health equity.
3. A methylation risk score for chronic kidney disease: a HyperGEN study
4. Variant level heritability estimates of type 2 diabetes in African Americans
5. Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations
6. Meta-analysis of genome-wide association studies of stable warfarin dose in patients of African ancestry
7. Returning integrated genomic risk and clinical recommendations: The eMERGE study
8. Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease
9. Risk scores for major bleeding from direct oral anticoagulants: comparing predictive performance in patients with atrial fibrillation
10. Education and electronic medical records and genomics network, challenges, and lessons learned from a large-scale clinical trial using polygenic risk scores
11. Genome-Wide Association Study of Apparent Treatment-Resistant Hypertension in the CHARGE Consortium: The CHARGE Pharmacogenetics Working Group
12. Genome-wide meta-analysis of SNP-by9-ACEI/ARB and SNP-by-thiazide diuretic and effect on serum potassium in cohorts of European and African ancestry
13. Genome-wide polygenic score to predict chronic kidney disease across ancestries
14. Utility of a Systolic Blood Pressure Polygenic Risk Score With Chlorthalidone Response.
15. Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations
16. Best–worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy
17. Outcomes of Individuals With and Without Heart Failure Presenting With Acute Coronary Syndrome
18. Pharmacogenomic Profiling of Pediatric Patients on Psychotropic Medications in an Emergency Department
19. Abstract 14063: Eight Pharmacokinetic-Related Genetic Variants Were Not Associated With Bleeding From Direct Oral Anticoagulants in Non-Valvular Atrial Fibrillation Patients
20. Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection
21. Residual risk for coronary heart disease events and mortality despite intensive medical management after myocardial infarction
22. Key Contextual Factors Involved with Participation in Medical and Genomic Screening and Research for African American and Caucasian Americans: A Qualitative Inquiry American Journal of Community Genetics
23. Polygenic Risk for Type 2 Diabetes in African Americans
24. Polygenic Risk for Type 2 Diabetes in African Americans
25. A methylation risk score for chronic kidney disease: a HyperGEN study
26. Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data
27. Racial differences in adult-onset MRI-negative temporal lobe epilepsy
28. Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing
29. Genetic deletion of 12/15 lipoxygenase promotes effective resolution of inflammation following myocardial infarction
30. Racial disparities in temporal lobe epilepsy
31. A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing
32. Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
33. Differential Impact of Risk Factors in Blacks and Whites in the Development of Atrial Fibrillation : the Reasons for Geographic And Racial Differences in Stroke (REGARDS) Study
34. Strong protective effect of theAPOL1p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease
35. Returning integrated genomic risk and clinical recommendations: The eMERGE study
36. Participant-guided development of bilingual genomic educational infographics for Electronic Medical Records and Genomics Phase IV study.
37. Abstract 17501: Splenic CD169+Tim4+ Marginal Zone Metallophilic Macrophages Are Essential for Wound Healing and Resolution of Inflammation After Myocardial Infarction
38. Improvement in Kidney Function After Ventricular Assist Device Implantation and Its Influence on Thromboembolism, Hemorrhage, and Mortality
39. Influence of statin therapy at time of stroke onset on functional outcome among patients with atrial fibrillation
40. Risk factors affecting polygenic score performance across diverse cohorts
41. P508: Medically-actionable disease risk variants in a diverse population
42. 31 - Principles of Genetics
43. High-Sensitivity C-Reactive Protein and Risk of Stroke in Atrial Fibrillation (from the Reasons for Geographic and Racial Differences in Stroke Study)
44. Effect of Left Ventricular Systolic Dysfunction on Response to Warfarin
45. US Mortality : Influence of Race, Geography and Cardiovascular Risk Among Participants in the Population-Based REGARDS Cohort
46. Paroxysmal atrial fibrillation and the hazards of under-treatment
47. Severity of Hypertension Mediates the Association of Hyperuricemia With Stroke in the REGARDS Case Cohort Study
48. Circulating myocardial microRNAs from infarcted hearts are carried in exosomes and mobilise bone marrow progenitor cells
49. Hypertension severity, apparent treatment resistant hypertension and hyperuricemia in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study
50. 278 Eight Pharmacokinetic-related Genetic Variants Were Not Associated with Bleeding from Direct Oral Anticoagulants in Non-valvular Atrial Fibrillation Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.